Skip to main content
. 2022 Nov 21;10:1077937. doi: 10.3389/fchem.2022.1077937

FIGURE 7.

FIGURE 7

PAI of orthotopic prostate cancer with integrin αvβ3 targeted probes based on ICG (cRGD–ICG). (A) In vivo integrin αvβ3 PAI images merged with US images. (B) PAI signal varied from depths at 12 h [reproduced from (Qiu et al., 2020) with permission from Springer Nature].